What Can you Expect in 2026?
Are you investing significant time and resources into allogeneic cell therapy development, but donor variability still undermines manufacturing efficiency, product consistency, and clinical performance? The 4th Donor Selection & Cell Source Summit is designed to help you turn these challenges into opportunities for differentiation.
At this year's summit, you will:
- Learn how leading developers link donor attributes to manufacturing and clinical success to improve product performance and scalability
- Explore strategies to manage and accommodate donor variability to reduce risk and maintain product consistency across batches
- Discover high-throughput donor screening and characterization approaches to identify high-performing donors and improve manufacturing outcomes
What to Expect?
Attending Companies Include
Explore the Full Event Guide
- Discover donor selection strategies from Cellectis, Mesoblast, Atara Bio, and Caribou Bio to improve clinical outcomes
- Explore donor sourcing from cord blood, PBMCs, and iPSCs to benchmark strategies, and gain clarity on where the field is moving
- Review the full agenda, speakers, and sessions to align team priorities
- Identify valuable networking opportunities to maximize connections with peers and providers
Explore the Agenda
Discover practical strategies to improve donor selection, reduce variability, and strengthen manufacturing and clinical outcomes.
Partner With Us
Position your brand alongside the organizations helping allogeneic developers build fit-for-purpose donor strategies.
Join Microbiome Experts
Connect with experts across donor operations, manufacturing, clinical development, and supply chain to build valuable partnerships.